Brian D. Richards
Impact in
- Clinical Psychology top 0.5%
- Psychedelics and Drug Studies
- Biological Psychiatry top 2%
- Tryptophan and brain disorders
Papers in
-
- Psychedelics and Drug Studies 6
- Eating Disorders and Behaviors 1
-
- Cannabis and Cannabinoid Research 4
- Co-authors
- Roland R. GriffithsWilliam A. RichardsMatthew W. JohnsonMary P CosimanoMichael A. CarducciAnnie UmbrichtRobert L. JesseUna D. McCann
- Journals
- Journal of Psychopharmacology (2 papers)Cancer (1 paper)Psychology of Addictive Behaviors (1 paper)Frontiers in Psychiatry (1 paper)Neuropsychopharmacology (1 paper)
- Partner nations
- United StatesUnited KingdomFinland
In The Last Decade
Brian D. Richards
8 papers receiving 2.5k citations
Hit Papers
Peers
Comparison fields: 5 of 73
- Clinical Psychology 2.4k
- Biological Psychiatry 163
- Cellular and Molecular Neuroscience 1.0k
- Organic Chemistry 1.4k
- Toxicology 138
Countries citing papers authored by Brian D. Richards
This map shows the geographic impact of Brian D. Richards's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian D. Richards with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian D. Richards more than expected).
Fields of papers citing papers by Brian D. Richards
This network shows the impact of papers produced by Brian D. Richards. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian D. Richards. The network helps show where Brian D. Richards may publish in the future.
Co-authors
The 24 scholars most cited alongside Brian D. Richards, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 33 | |
| 2 | 2023 | 26 | |
| 3 | 2021 | 60 | |
| 4 | Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors Hit paper breakdown → | 2017 | 326 |
| 5 | Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Hit paper breakdown → | 2016 | 1376 |
| 6 | 2012 | 41 | |
| 7 | Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects Hit paper breakdown → | 2011 | 612 |
| 8 | 2006 | 70 |
About Brian D. Richards
Brian D. Richards is a scholar working on Clinical Psychology, Pharmacology, Toxicology, Complementary and alternative medicine and Organic Chemistry, having authored 8 papers that have together received 2.5k indexed citations. Recurring topics across this work include Psychedelics and Drug Studies (6 papers), Cannabis and Cannabinoid Research (4 papers), Chemical synthesis and alkaloids (4 papers), Complementary and Alternative Medicine Studies (2 papers), Neurotransmitter Receptor Influence on Behavior (1 paper), Obesity, Physical Activity, Diet (1 paper), Eating Disorders and Behaviors (1 paper) and Poisoning and overdose treatments (1 paper). The work is most often cited by research in Clinical Psychology (2.4k citations), Biological Psychiatry (163 citations), Cellular and Molecular Neuroscience (1.0k citations), Organic Chemistry (1.4k citations) and Toxicology (138 citations). Brian D. Richards has collaborated with scholars based in United States, United Kingdom and Finland. Frequent co-authors include Roland R. Griffiths, William A. Richards, Matthew W. Johnson, Mary P Cosimano, Michael A. Carducci, Annie Umbricht, Robert L. Jesse, Una D. McCann, Frederick S. Barrett and Katherine A. MacLean. Their work appears in journals such as Journal of Psychopharmacology, Cancer, Psychology of Addictive Behaviors, Frontiers in Psychiatry and Neuropsychopharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.